VivoSeq
Other

Post-Surgical

0

Pipeline Programs

6

Active Trials

2

Companies Involved

Post-surgical is an early-stage landscape with 0 programs across 2 companies. The most active players are Pfizer, Endo Pharmaceuticals.

Pipeline Metrics

Competitive Density

21/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

79/100

Attrition Rate

13/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

23

clinical trials

Completed11 · 48%
Recruiting4 · 17%
Unknown status3 · 13%
Terminated2 · 9%
Active, not recruiting2 · 9%
Withdrawn1 · 4%

Trial Activity

23 trials

Healing Ointment Usage Post-surgical Procedure
Completed·GGalderma R&D·Phase 4·NCT05686928·15 enrolled
A Study of Acetaminophen for Post Surgical Dental Pain
Completed·NNevakar, Inc.·Phase 2·NCT04018612·110 enrolled
Stem Cell Fistula Plug in Post Surgical Leak Fistulas
Completed·MMayo Clinic·Phase 1·NCT02807389·2 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)